FDA Adverse Event Malfunction Summary report: N

ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE

MDR report key: 19862860 · Received July 30, 2024

Report

Report Number
2916596-2024-04679
Event Type
Malfunction
Date Received
July 30, 2024
Date of Event
July 10, 2024
Report Date
January 6, 2025
Manufacturer
THORATEC CORPORATION
Product Code
DTZ
PMA / PMN Number
K141492
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO FURTHER INFORMATION WAS PROVIDED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED ONCE THE MANUFACTURER¿S INVESTIGATION IS COMPLETED.

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION CONCLUSION: THE REPORT OF A LEAK DURING PRIMING COULD NOT BE CONFIRMED THROUGH THIS EVALUATION AS NO PRODUCT OR IMAGES WERE SUBMITTED FOR EVALUATION. THE DEVICE MANUFACTURER (EUROSETS) WAS UNABLE TO IDENTIFY THE ROOT CAUSE OF THE PROBLEM BASED ONLY ON THE PROVIDED INFORMATION. MULTIPLE REQUESTS FOR ADDITIONAL INFORMATION REGARDING THIS EVENT WERE SUBMITTED TO THE ACCOUNT; HOWEVER, NO RESPONSE HAS BEEN RECEIVED AT THIS TIME. THE EUROSETS AMG PMP OXYGENATOR, LOT #9945208, WAS NOT RETURNED FOR EVALUATION. WITH ONLY THE AVAILABLE INFORMATION, THE ROOT CAUSE OF THE REPORTED EVENT WAS UNABLE TO BE DETERMINED BY THE EXTERNAL MANUFACTURER (EUROSETS). ALTHOUGH LEAKING WAS UNABLE TO BE CONFIRMED THROUGH THIS EVALUATION, ADDITIONAL INVESTIGATION OF OXYGENATOR LEAKING ISSUES HAS BEEN INITIATED BY ABBOTT AND SENT TO EUROSETS (OXYGENATOR SUPPLIER/MANUFACTURER) THROUGH A SUPPLIER CORRECTIVE ACTION REQUEST. THE PRODUCTION DOCUMENTATION FOR THE EUROSETS AMG PMP OXYGENATOR, LOT #9945208, WAS REVIEWED BY THE EXTERNAL MANUFACTURER (EUROSETS) AND SHOWED THAT ALL TESTS MADE IN THE PRODUCTION PROCESS WERE COMPLIANT WITH THE TECHNICAL SPECIFICATIONS. THE EUROSETS AMG PMP INSTRUCTIONS FOR USE (IFU), REV. 05, IS CURRENTLY AVAILABLE. UNDER THE LIST OF WARNINGS, THE IFU WARNS THAT DURING USE, A SPARE OXYGENATOR MUST ALWAYS BE AVAILABLE AND ALSO WARNS THAT THE DEVICE HAS TO BE CAREFULLY AND CONTINUOUSLY CHECKED BY QUALIFIED HEALTHCARE PROFESSIONALS THROUGHOUT THE PROCEDURE. THE IFU WARNS TO CAREFULLY CHECK THE DEVICE SEAL DURING PRIMING AND OPERATION. IF YOU NOTICE LEAKAGE DURING PRIMING OR OPERATION, REPLACE THE DEFECTIVE DEVICE FOLLOWING GOOD PERFUSION PRACTICES. ALSO, UNDER THE SECTION TITLED ¿SET UP¿, THE IFU WARNS TO ¿CARRY OUT A VISUAL INSPECTION AND CAREFULLY CHECK THE DEVICE BEFORE USE. TRANSPORT AND/OR STORAGE CONDITIONS OTHER THAN THOSE PRESCRIBED MAY HAVE CAUSED DAMAGE TO THE DEVICE.¿ UNDER THE SECTION TITLED ¿OXYGENATOR REPLACEMENT¿, THIS DOCUMENT STATES THAT A SPARE OXYGENATOR MUST ALWAYS BE AVAILABLE DURING PERFUSION. AFTER 6 HOURS OF USE WITH BLOOD OR IF PARTICULAR SITUATIONS OCCUR, WHICH MAY LEAD THE PERSON RESPONSIBLE FOR PERFUSION TO DETERMINE THE SAFETY OF THE PATIENT MAY BE COMPROMISED (INSUFFICIENT OXYGENATOR PERFORMANCE, LEAKS, ABNORMAL BLOOD PARAMETERS, ETC.), FOLLOW THE PROCEDURE OUTLINED IN THE IFU FOR OXYGENATOR REPLACEMENT. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE OXYGENATOR WAS BEING PRIMED AND STARTED TO LEAK. THE PERFUSIONIST REMOVED THE OXYGENATOR FROM THE CIRCUIT AND REPLACED IT WITH A NEW ONE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
254405 ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE OXYGENATOR, CARDIOPULMONARY BYPASS DTZ THORATEC CORPORATION US5062 9945208

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown